Advertisement

Smallpox as a Weapon for Bioterrorism

  • J. Michael Lane
  • Lila Summer
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Keywords

Smallpox Vaccination Smallpox Vaccine Smallpox Virus Vaccine Supply Containment Method 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alibek, K. (1999). Biohazard. New York: Random House, Inc.Google Scholar
  2. Arness, M.K., Eckart, R.E., Love, S.S., Atwood, J.E., Wells, T.S., Engler, R.J., Collins, L.C., Ludwig, S.L., Riddle, J.R., Grabenstein, J.D., Tornberg, D.N. (2004) Myopericarditis following smallpox vaccination. American Journal of Epidemiology. 160:642–51.PubMedCrossRefGoogle Scholar
  3. BBC2 England. (2002). Smallpox 2002. Produced by Simon Chinn, in association with the Learning Channel and Granada International, written by Daniel Percival.Google Scholar
  4. Bicknell, W.J. (2002). The case for voluntary smallpox vaccination. N. Engl. J. Med. 346:1323–1325.PubMedCrossRefGoogle Scholar
  5. Bonnilla-Guerrero, R., and Poland, G. (2003). Smallpox vaccines: current and future. J. Lab. Clin. Med. 142:252–257.CrossRefGoogle Scholar
  6. Born, T.L., Morrison, L.A., Esteban, D.J., VandenBos, T., Thebeau, L.G. Chen, M., Spriggs, M.K., Sims, J.E., Buller, R.M. A poxvirus protein that binds to and inactivates IL-18 and inhibits NK cell response. (2000) J. Immunology 164:3246–54.Google Scholar
  7. Bozzette, S.A., Boer, R., Bhatnagar, V., Brower, J.L., Keeler, E.B., Morton, S.C., and Stoto, M.A. (2003). A model for a smallpox-vaccination policy. N. Engl. J. Med. 348:416–425.PubMedCrossRefGoogle Scholar
  8. Bray, M., Buller, M. (2004) Looking back at smallpox. Clin Infect Dis 38:882–9.PubMedCrossRefGoogle Scholar
  9. Bray, M., Roy, C.J. (2004) Antiviral prophylaxis of smallpox. Journal of Antimicrobial Chemotherapy. 54:1–5.PubMedCrossRefGoogle Scholar
  10. Breman, J.G., Arita, I., and Fenner, F. (2003). Preventing the return of smallpox. N. Engl. J. Med. 348:463–466.PubMedCrossRefGoogle Scholar
  11. Breman, J.G., and Henderson, D.A. (2002). Diagnosis and management of smallpox. N. Engl. J. Med. 346:1300–1308.PubMedCrossRefGoogle Scholar
  12. Broad, W.J. (2002). U.S. to vaccinate 500,000 workers against smallpox. The New York Times, July 7, 2002, Section A1.Google Scholar
  13. Bush, G.W. (2002). Protecting Americans: Smallpox Vaccination Program. http://www.whitehouse.gov/news/releases/2002/12/20021213-1.html.Google Scholar
  14. Cassimatis, D.C., Atwood, J.E., Engler, R.M., Linz, P.E., Grabenstein, J.D., Vernalis, M.N. (2004) Smallpox vaccination and myopericarditis: a clinical review. Journal of the American College of Cardiology. 43:1503–10.PubMedCrossRefGoogle Scholar
  15. Centers for Disease Control. (1980). Smallpox vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 29:417–420.Google Scholar
  16. Centers for Disease Control and Prevention (2002a). Smallpox images. http://www.bt.cdc.gov/agent/smallpox/smallpox-images/index.asp.Google Scholar
  17. Centers for Disease Control and Prevention. (2002b). Diagnostic algorithm for rash illnesses. http://www.bt.cdc.gov/agent/smallpox/diagnosis/evalposter.asp.Google Scholar
  18. Centers for Disease Control and Prevention. (2002c). Smallpox response plan and guidelines. Guide C. Legal and quarantine authority. http://www.bt.cdc.gov/agent/smallpox/response-plan/files/guide-c-part-2.pdf.Google Scholar
  19. Centers for Disease Control and Prevention (2002d). CDC telebriefing transcript smallpox vaccine June 20, 2002. http://www.cdc.gov/od/oc/media/transcripts/t020620.htm.Google Scholar
  20. Centers for Disease Control and Prevention (2003a). Smallpox response plan and guidelines (version 3.0). http://www.bt.cdc.gov/agent/smallpox/response-plan/index.asp.Google Scholar
  21. Centers for Disease Control and Prevention (2003b). Smallpox response plan and guidelines (version 3.0). Guide D—Specimen collection and transport. http://www.bt.cdc.gov/agent/smallpox/response-plan/files/guide-d.doc.Google Scholar
  22. Centers for Disease Control and Prevention (2003c). Smallpox response plan and guidelines (version 3.0). Guide F—Environmental control of smallpox virus. http://www.bt.cdc.gov/agent/smallpox/response-plan/guide-f.doc.Google Scholar
  23. Centers for Disease Control and Prevention (2003d). Smallpox response plan and guidelines (version 3.0). Annex 1. Medical management of smallpox patients and vaccination complications. http://www.bt.cdc.gov/agent/smallpox/response-plan/annex-1.doc.Google Scholar
  24. Centers for Disease Control and Prevention. (2003e). Smallpox vaccination and adverse events. Guidelines for clinicians. MMWR 52(RR04):RR04:1–28.Google Scholar
  25. Centers for Disease Control and Prevention. (2003f). Smallpox vaccination program status by state. http://www.cdc.gov/od/oc/media/spvaccin.htm.Google Scholar
  26. Centers for Disease Control and Prevention. (2003g). Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 52(RR-7).Google Scholar
  27. Connolly C. (2003). Bush inoculation plan near standstill. Medical professionals cite possible side effects, uncertainty of threat. The Washington Post Feb 24, Section A6.Google Scholar
  28. Cummings, J.F., Polhemus, M.E., Hawkes, C., Klote, M., Ludwig, G.V., Wortmann, G. (2004) Lack of vaccinia viremia after smallpox vaccination. (2004) Clinical Infectious Diseases. 38:456–8.PubMedCrossRefGoogle Scholar
  29. Dalgaard, J.B. (1957). Fatal myocarditis following smallpox vaccination. Am. Heart J. 54:156–157.PubMedCrossRefGoogle Scholar
  30. Damon, I., and Regnery, R. (2003). Orthopoxviruses. In: Marrey, P.C., and Baron, E.J. (eds.), Manual of Clinical Microbiology, 8th ed. American Society of Microbiology Press, Washington, D.C.Google Scholar
  31. DeRugy, V., and Pena, C.V. (2002). Responding to the threat of smallpox bioterrorism. Policy Anal. 434:1–16.Google Scholar
  32. Dixon, C.W. (1948). Smallpox in Tripolitania, 1946; an epidemiological and clinical study of 500 cases, including trials of penicillin treatment. J Hyg. 46:35–77.CrossRefGoogle Scholar
  33. Dixon, C.W. (1962). Smallpox. Little Brown and Company, Boston.Google Scholar
  34. Downie, A.W., Meikeljohn, M., St. Vincent, L., Rao, A.R., Sundara Babu, B.V., and Kempe, C.H. (1965). The recovery of smallpox virus from patients and their environment in a smallpox hospital. Bull. WHO 33:615–622.PubMedGoogle Scholar
  35. Drexler, I, Staib, C., Kastenmuller, W., Stevanoivic, S., Schmidt, B., Lemonnier, F.A., Rammensee, H.-G., Busch, D.H., Bernhard, H., Erfle, V., and Sutter, G. (2003). Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc. Soc. NH. Acad. Sci. 100:217–222.CrossRefGoogle Scholar
  36. Earl, P.L., Americo, J.L., Wyatt, L.S., Eller, L.A., Whitbeck, J.C., Cohen, G.H., Eisenberg, R.J., Hartmann, C.J., Jackson, D.L., Kulesh, D.A., Martinez, M.J., Miller, D.M., Mucker, E.M., Shamblin, J.D., Zwiers, S.H., Huggins, J.W., Jahrling, P.B., Moss, B. (2004) Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 428:182–5.PubMedCrossRefGoogle Scholar
  37. Eckart, R.E., Love, S.S., Atwood, J.E., Arness. M.K., Cassimatis, D.C., Campbell, C.L., Boyd, S.Y., Murphy, J.G., Swerdlow, D.L., Collins, L.C., Riddle, J.R., Tornberg, D.N., Grabenstein, J.D., Engler, R.J. Department of Defense Smallpox Vaccination Clinical Evaluation Team. (2004) Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. Journal of the American College of Cardiology. 44:201–5.PubMedCrossRefGoogle Scholar
  38. Eichner, M. (2003). Case isolation and contact tracing can prevent the spread of smallpox. Am. J. Epidemiol. 158:118–128.PubMedCrossRefGoogle Scholar
  39. Enserink, M. (2002). Did bioweapons test cause a deadly smallpox outbreak? Science 296:2116–2117.PubMedCrossRefGoogle Scholar
  40. Eubank, S., Guclu, H., Kumar, V.S., Marathe, M.V., Srinivasan, A., Toroczkai, Z., Wang, N. (2004) Modelling disease outbreaks in realistic urban social networks. Nature. 429:180–4.PubMedCrossRefGoogle Scholar
  41. Fackelmann, K. (2003). Handheld bioterror detectors in works. USA Today, July 10, 2003, p. 6D.Google Scholar
  42. Fenner, F., Henderson. D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988). Smallpox and Its Eradication. WHO, Geneva.Google Scholar
  43. Ferry, B.J. (1977). Adverse reactions after smallpox vaccination. Med. J. Australia 2:180–183.Google Scholar
  44. Finlay-Jones, L.R. (1964). Fatal myocarditis after vaccination against smallpox: report of a case. N. Engl. J. Med. 270:41–42.PubMedCrossRefGoogle Scholar
  45. Foege, W.H., Lane, J.M., and Millar, J.D. (1971). Selective epidemiologic control in smallpox eradication. Am. J. Epidemiol. 94:311–315.PubMedGoogle Scholar
  46. Foege WH, Millar JD, Henderson DA. (1975) Smallpox eradication in West and Central Africa. Bull. WHO 52: 209–222.PubMedGoogle Scholar
  47. Frey, S.E., Couch, R.B., Tacket, C.O., Treanor, J.J., Wolff, M., and Newman, F.K. (2002). Clinical responses to undiluted and diluted smallpox vaccine. N. Engl. J. Med. 346:1265–1274.PubMedCrossRefGoogle Scholar
  48. Fulginiti, V.A., Papier, A., Lane, J.M., Neff, J.M., and Henderson, D.A. (2003). Smallpox vaccination (vaccinia): a review. Part I. Background, vaccination technique, normal vaccination and revaccination and expected normal reactions. Clin. Infect. Dis. 37:241–250.PubMedCrossRefGoogle Scholar
  49. Fulginiti, V.A., Papier, A., Lane, J.M., Neff, J.M., and Henderson, D.A. (2003). Smallpox vaccination (vaccinia): a review. Part II. Adverse events. Clin. Infect. Dis. 37:251–271.PubMedCrossRefGoogle Scholar
  50. Gani, R., Leach, S. (2001). Transmission potential of smallpox in contemporary populations. Nature 414:748–751.PubMedCrossRefGoogle Scholar
  51. Garde, V., Harper, D., Fairchok, M.P. (2004) Tertiary contact vaccinia in a breastfeeding infant. JAMA. 291:725–7.PubMedCrossRefGoogle Scholar
  52. Gellman, B. (2002). Four nations thought to possess smallpox. The Washington Post, November 5, 2002, A1.Google Scholar
  53. Gettleman, J. (2002). Two hospitals refuse to join Bush’s plan for smallpox. The NewYork Times, December 19, 2002, A16.Google Scholar
  54. Grabenstein, J.D., and Winkenwerder, W. (2003). US military smallpox vaccination program experience. J.A.M.A. 289:3278–3282.PubMedGoogle Scholar
  55. Halsell, J.S., Riddle, J.R., Atwood, J.E., Gardner, P., Shope, R., Poland, G.A., Gray, G.C., Ostroff, S., Eckart, R.E., Hospenthal, D.R., Gibson, R.L., Grabenstein, J.D., Arness, M.K., and Tornbery, D.N. (2003). Myopericarditis following smallpox vaccination among vaccinia-naïve US military personnel. J.A.M.A. 289:3283–3289.PubMedGoogle Scholar
  56. Hammarlund, E., Lewis, M.W., Hansen, S.G., Strelow, L.I., Nelson, J.A., Sexton, G.J., Hanifin, J.M., and Slifka, M.K. (2003). Duration of antiviral immunity after smallpox vaccination. Nature Med. (online), August 17, 2003. http://www.nature.com/naturemedicine/.Google Scholar
  57. Harper, G.J. (1961). Airborne micro-organisms: survival test with four viruses. J. Hyg. 59:479–486.Google Scholar
  58. Hastert, J.D. (2002). House Speaker Hastert introduces the Speaker’s Task Force for a Drug Free America. http://speaker.house.gov/library/drugs/010921task.asp.Google Scholar
  59. Heiner, G.G., Fatima, N., and McCrumb, F.R. (1971). A study of intrafamilial transmission of smallpox. Am.J. Epidemiol. 94:316–326.PubMedGoogle Scholar
  60. Henderson, D.A. (2003). Commentary on Dr Alan Zelikoff’s epidemiological analysis of the Aralsk outbreak (N3). Crit. Rev. Microbiol. 29:169–170.PubMedGoogle Scholar
  61. Henderson, D.A., Borio, L.L., and Lane, J. M. (2003). Smallpox and vaccinia. In: Plotkin and Orenstein (eds.), Vaccines, 4th ed. W.B. Saunders Company, New York.Google Scholar
  62. Henderson, D.A., Inglesby, T.V., Bartlett, J.G., Ascher. M.S., Eitzen, E., Jahrling, P.B., Hauer, J., Layton, M., McDade, J., Osterholm, M.T., O’Toole. T., Parker, G., Perl, T., Russell, P, K., and Tonat, K. (1999). Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. J.A.M.A. 281:2127–2137 [review].PubMedGoogle Scholar
  63. Hepburn, M.J., Dooley, D.P., Murray, C.K., Hospenthal, D.R., Hill, B.L., Nauschuetz, W.N., Davis, K.A.m Crouch, H.K., McAllister, C.K.(2004) Frequency of vaccinia virus isolation on semipermeable versus nonocclusive dressings covering smallpox vaccination sites in hospital personnel. American Journal of Infection Control. 32:126–30.PubMedCrossRefGoogle Scholar
  64. Hopkins, D.R., Lane, J.M., Cummings, E.C., and Millar, J.D. (1971). Two funeral-associated smallpox outbreaks in Sierra Leone. Am. J. Epidemiol. 94:341–347.PubMedGoogle Scholar
  65. Jackson, R.J., Ramsay, A.J., Christensen, C.D., Beaton, S., Hall, D.F., and Ramshaw, I.A. (2001). Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol. 75:1205–1210.PubMedCrossRefGoogle Scholar
  66. Jahrling, P.B., Hensley, L.E., Martinez, M.J., LeDuc, J.W., Rubins, K.H., Relman, D.A., Huggins, J.W., (2004) Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc National Acad Sci. 101:15197–204.Google Scholar
  67. Johnson, K., Locy, T., and Manning, A. (2003). Terrorists’ most likely weapon here? Bombs. USA Today, May 16, 2003, 1A.Google Scholar
  68. Kennedy, J.S., Frey, S.E., Yan, L., Rothman, A.L., Cruz, J., Newman, F.K., Orphin, L., Belshe, R.B., Ennis. F.A., (2004) Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. Journal of Infectious Diseases. 190:1286–94.PubMedCrossRefGoogle Scholar
  69. Knollenberg, B. (1954). General Amherst and germ warfare. Mississippi Valley Hist. Rev. 41:489–494.CrossRefGoogle Scholar
  70. Koplan, J.P., and Foster, S.O. (1979). Smallpox: clinical types, causes of death, and treatment. J. Infect. Dis. 140:440–441.PubMedGoogle Scholar
  71. Kulesh, D.A., Baker, R.O., Loveless, B.M., Norwood, D., Zwiers, S.H., Mucker, E., Hartmann, C., Herrera, R., Miller, D., Christensen, D., Wasieloski, L.P Jr., Huggins, J., Jahrling, P.B. (2004) Smallpox and pan-orthopox virus detection by real-time 3’-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. Journal of Clinical Microbiology. 42:601–7.PubMedCrossRefGoogle Scholar
  72. Lane, J.M., and Goldstein, J. (2003). Evaluation of 21ist century risks of smallpox vaccination and policy options. Ann. Intern. Med. 138:488–493.PubMedGoogle Scholar
  73. Lane, J.M., and Fulginiti, V.A. (2003). Transmission of vaccinia virus, and rationale for measures for prevention. Clin. Infect. Dis. 37:281–284.PubMedCrossRefGoogle Scholar
  74. Langbein, B. (2003). New compounds show promise as smallpox drugs. Reuters, July 31, 2003.Google Scholar
  75. LeDuc, J.W., Damon, I., Relman, D.A., Huggins, J., and Jahrling, P.B. (2002). Smallpox research activities: U.S. interagency collaboration, 2001. Emerg. Infect. Dis. 8:743–745.PubMedGoogle Scholar
  76. LeDuc J.W., and Jahrling, P.B. (2001). Strenthening national preparedness for smallpox; an update. Emerg. Infect. Dis. 7:155–157.PubMedGoogle Scholar
  77. Legrand, J., Viboud, C., Boelle, P.Y., Valleron, A.J., Flahault, A. (2004) Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiology & Infection. 13:19–25.CrossRefGoogle Scholar
  78. Linzer, D. (2003). U.S.team in Iraq finds no smallpox. The Atlanta Journal-Constitution. September 19, 2003, A14.Google Scholar
  79. Mack, T.M. (1972). Smallpox in Europe, 1950–1971. J. Infect. Dis. 125:161–169.PubMedGoogle Scholar
  80. Mack, T.M. (2003). A different view of smallpox and vaccination. N. Engl. J. Med. 348:460–463.PubMedCrossRefGoogle Scholar
  81. Mack, T.M., Thomas, D.B., Ali, A., and Khan, M.M. (1972). Epidemiology of smallpox in West Pakistan I: acquired immunity and the distribution of disease. Am. J. Epidemiol. 95:157–168.PubMedGoogle Scholar
  82. Mahy, B.W.J. (2003). An overview on the use of a viral pathogen as a bioterrorism agent: why smallpox? Antiviral Res. 57:1–5.PubMedCrossRefGoogle Scholar
  83. Mangold, T., Gilmore J., and Molloy P. (1998). Plague War, PBS Videotape, Alexandria, VA.Google Scholar
  84. McCurdy, L.H., Larkin, B.D., Martin, J.E., Graham, B.S. (2004) Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clinical Infectious Diseases. 38:1749–53.PubMedCrossRefGoogle Scholar
  85. McKenzie, P.J., Githens, J.H., Harwood, M.E., Roberts, J.F., Rao, A.R., and Kempe, C.H. (1965). Haemorrhagic smallpox. 2. Specific bleeding and coagulation studies. Bull. WHO 33:773–782.PubMedGoogle Scholar
  86. Meltzer, M.I., Damon, I., LeDuc, J.W., and Millar, J.D. (2001). Modeling potential responses to smallpox as a bioterrorist weapon. Emerg. Infect. Dis. 7:959–969.PubMedCrossRefGoogle Scholar
  87. Moss, B. (2001). Poxviridae: the viruses and their replication. In: Knipe, D.M., and Howley, P.M. (eds), Fields Virology, 4th ed., chap. 84. Lippincott Williams & Wilkins, Philadelphia.Google Scholar
  88. Mukherjee, M.K., Sarkar, J.K., and Mitra, A.S. (1974). Pattern of intrafamilial transmission of smallpox in Calcutta, India. Bull. WHO 51:215–219.Google Scholar
  89. NBC10News. (July 10, 2003). Government monitoring Philadelphia air for biotoxins. Sensors check for anthrax, smallpox, in 31 cities. http://www.nbc10.com/2323887/detail.html.Google Scholar
  90. Neff, J.M., Lane, J.M., Fulginiti, V.A., and Henderson, D.A. (2002). Contact vaccinia—transmission of vaccinia from smallpox vaccination. J.A.M.A. 288:1901–1905.PubMedCrossRefGoogle Scholar
  91. Neyts, J., and De Clercq E. (2003). Therapy and short-term prophylaxis of poxvirus infections: historical background and perspective. Antiviral Res. 57:25–33.PubMedCrossRefGoogle Scholar
  92. Olson, E. (2003). Panel urges shift of focus in preparing for smallpox. The New York Times, August 13, 2003, A15.Google Scholar
  93. O’Toole, T., and Inglesby, T. (2001). Shining light on dark winter. Baltimore: Johns Hopkins Center for Civilian Defense Strategies. Accessed July 10, 2003 at www.hopkins-biodefense.org/lessons.html.Google Scholar
  94. Oxford, J. (2003). Smallpox bioterrorism unlikely: populations are easily protected. Basic Notes, March 25, 2003.Google Scholar
  95. Piller, C. (2002). Smallpox strike called unlikely. The Los Angeles Times, December 13, 2002.Google Scholar
  96. Rao, A.R., Jacob, E.S., Kamalakshi, S., Appaswamy, S., and Bradbury. (1968). Epidemiological studies of smallpox. A study of intrafamilial transmission in a series of 254 infected families. Ind. J. Med. Res. 56:1826–1854.Google Scholar
  97. Rao, A.R. (1972). Smallpox. The Kothari Book Depot, Bombay.Google Scholar
  98. Roos, R. (2003). Scientists research antidotes to super mousepox virus. CIDRAP News. http://www.cidrap.umn.edu/cidrap/content/bt/smallpox/news/nov0603/mousepox.htmlGoogle Scholar
  99. Ropp, S.L., Jin, Q., Knight, J.C. Massung, R.F., and Esposito, J.J. (1995). PCR strategy for identification and differentiation of smallpox and other orthopoxviruses. J Clin. Microbiol. 33:2069–2076.PubMedGoogle Scholar
  100. Sarkar, J.K., Mitra, A, C., Mukherjee, M.K., and De, S.K. (1973). Virus excretion in smallpox. 2. Excretion in the throats of household contacts. Bull. WHO 48:523–527.PubMedGoogle Scholar
  101. Schriewer J., Buller, R.M., Owens, G. (2004) Mouse models for studying orthopoxvirus respiratory infection. Methods in Molecular Biol. 264:289–308.Google Scholar
  102. Seward, J.E, Galil, K, Damon, I, Norton, S.A, Rotz, L., Harpaz, R., Cono, J., Marin, M., Hutchins, S., Chaves, S.S., McCauley, M.M. (2004) Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002–2004 Clin Infect Dis 39:1477–84.PubMedCrossRefGoogle Scholar
  103. Smee, D.F., and Sidwell, R.W. (2003). A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 57:41–52.PubMedCrossRefGoogle Scholar
  104. Smith, G.L., Vanderplasschen, A., and Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen. Virol. 83:2914–2931 [review].Google Scholar
  105. Sofi, I.M., Kulesh, D.A., Saleh, S.S., Damon, I.K., Esposito, J.J., Schmaljohn, A.L., and Jahrling, P.B. (2003). Real-time PCR assay to detect smallpox virus. J. Clin. Microbiol. 41:3835–3839.CrossRefGoogle Scholar
  106. Sommer, A., and Foster, S.O. (1974). The 1972 Smallpox outbreak in Khulna municipality, Bangladesh. 1. Methodology and epidemiologic findings. Am. J. Epidemiol. 99:291–302.PubMedGoogle Scholar
  107. Stevenson, R.W., and Stolberg, S.G. (2002). Bush lays out plan on smallpox shots; military is first. The New York Times, December 14, 2002, Section A1.Google Scholar
  108. Stevenson, R.W., and Altman, L.K. (2002). Smallpox shots will start soon under Bush plan. The New York Times, December 12, 2002, A1.Google Scholar
  109. Talbot, T.R., Stapleton, J.T., Brady, R.C., Winokur, P.L., Bernstein, D.I., Germanson, T., Yoder, S.M., Rock, M.T., Crowe, J.E. Jr., Edwards, K.M. (2004) Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA. 292:1205–12.PubMedCrossRefGoogle Scholar
  110. Thomas, G. (1974). Air sampling of smallpox virus. J. Hyg. 73:1–7.Google Scholar
  111. Thorpe, L.E., Mostashari, F., Karpati, A, M., Schwartz, S.P., Manning, S.E., Marx, M.A., Frieden, T.R. (2004) Mass smallpox vaccination and cardiac deaths, New York City, 1947. Emerging Infectious Diseases. 10:917–20.PubMedGoogle Scholar
  112. Vrantseva, Y. (2002). US paper to face Russian lawsuit. GAZETA, RU, December 5, 2002.Google Scholar
  113. Warrick, J. (2002). Iran said to be producing bioweapons. The Washington Post, May 15, 2002, A22.Google Scholar
  114. Wehrle, P.F., Posch, J., Richter, K.H., and Henderson, D.A. (1970). An airborne outbreak of smallpox in a German hospital and its significance with respect to other outbreaks in Europe. Bull. WHO 4:669–679.Google Scholar
  115. Wheelis, M. (1999). Biological warfare before 1914. In: Geissler, E., and van Courtland Moon J.E. (eds.), Biological and Toxin Weapons: Research and Use from the Middles Ages to 1945. Oxford University Press, New York, pp. 8–34.Google Scholar
  116. Whitley, R.J. (2003). Smallpox: a potential agent of bioterrorism. Antiviral Res. 57:7–12.PubMedCrossRefGoogle Scholar
  117. World Health Organization. (2005). http://www.who.int/emc/diseases/smallpox/slideset/index.htmGoogle Scholar
  118. Zelicoff, A.P. (2003). An epidemiological analysis of the 1971 smallpox outbreak in Aralsk, Kazakhstan. Crit. Rev. Microbiol. 129:97–108.Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • J. Michael Lane
    • 1
  • Lila Summer
    • 2
  1. 1.Smallpox Eradication ProgramCenters for Disease Control and PreventionAtlanta
  2. 2.A Human WritesAtlanta

Personalised recommendations